Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: Expert clinical opinion - Archive ouverte HAL Access content directly
Journal Articles Journal of Crohn's and Colitis Year : 2013

Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: Expert clinical opinion

(1) , (2) , (3) , (4) , (5) , (6) , (7, 8) , (9) , (10) , (11) , (12)
1
2
3
4
5
6
7
8
9
10
11
12

Abstract

Inflammatory bowel diseases (IBD), such as ulcerative colitis (UC) and Crohn's disease (CD) are organic inflammatory diseases, caused by chronic mucosal inflammation of the intestine. They are typically characterized by variable disease activity, often with repeated periods of intermittent disease activity and remission. Irritable bowel syndrome (IBS) is a non-inflammatory functional disorder and, by definition, presumes the absence of organic disease.1 As the presenting manifestations of IBD and IBS are similar and can include diarrhea, abdominal pain and bloating, obtaining a clinical diagnosis can be difficult, and further invasive diagnostic procedures may be required in order to obtain a confirmed diagnosis.

Dates and versions

hal-01701032 , version 1 (05-02-2018)

Identifiers

Cite

Gerhard Rogler, Xavier Aldeguer, Wolfgang Kruis, Anders Lasson, Ulrich Mittmann, et al.. Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: Expert clinical opinion. Journal of Crohn's and Colitis, 2013, 7 (8), pp.670 - 677. ⟨10.1016/j.crohns.2013.02.014⟩. ⟨hal-01701032⟩
133 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More